- Home
- NPCE vs CCIX Comparison
NPCE vs CCIX Comparison
Compare NPCE & CCIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NPCE
- CCIX
- Stock Information
- Founded
- NPCE 1997
- CCIX 2023
- Country
- NPCE United States
- CCIX United States
- Employees
- NPCE N/A
- CCIX N/A
- Industry
- NPCE Medical Specialities
- CCIX
- Sector
- NPCE Health Care
- CCIX
- Exchange
- NPCE Nasdaq
- CCIX Nasdaq
- Market Cap
- NPCE 355.5M
- CCIX 377.6M
- IPO Year
- NPCE 2021
- CCIX 2024
- Fundamental
- Price
- NPCE $11.97
- CCIX $10.44
- Analyst Decision
- NPCE Buy
- CCIX
- Analyst Count
- NPCE 6
- CCIX 0
- Target Price
- NPCE $15.83
- CCIX N/A
- AVG Volume (30 Days)
- NPCE 86.9K
- CCIX 5.7K
- Earning Date
- NPCE 03-04-2025
- CCIX 01-01-0001
- Dividend Yield
- NPCE N/A
- CCIX N/A
- EPS Growth
- NPCE N/A
- CCIX N/A
- EPS
- NPCE N/A
- CCIX N/A
- Revenue
- NPCE $76,452,000.00
- CCIX N/A
- Revenue This Year
- NPCE $23.46
- CCIX N/A
- Revenue Next Year
- NPCE $14.64
- CCIX N/A
- P/E Ratio
- NPCE N/A
- CCIX N/A
- Revenue Growth
- NPCE 27.00
- CCIX N/A
- 52 Week Low
- NPCE $5.45
- CCIX $10.00
- 52 Week High
- NPCE $18.15
- CCIX $11.17
- Technical
- Relative Strength Index (RSI)
- NPCE 58.55
- CCIX N/A
- Support Level
- NPCE $11.37
- CCIX N/A
- Resistance Level
- NPCE $12.65
- CCIX N/A
- Average True Range (ATR)
- NPCE 0.96
- CCIX 0.00
- MACD
- NPCE -0.05
- CCIX 0.00
- Stochastic Oscillator
- NPCE 48.94
- CCIX 0.00
About NPCE Neuropace Inc.
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
About CCIX Churchill Capital Corp IX Ordinary Shares
Churchill Capital Corp IX is a blank check company.